APOTEX INC. - SIGNET — Levothyroxine Importer Profile
Pharmaceutical Importer · #18 buyer for Levothyroxine · $785.2K import value · 33 shipments · CANADA · DGFT Verified
APOTEX INC. - SIGNET is the #18 importer of Levothyroxine from India with $785.2K in import value and 33 verified shipments. APOTEX INC. - SIGNET holds a 1.0% market share in Levothyroxine imports based in CANADA. The company sources from 1 verified supplier across 33 formulations shipped to 1 country.
APOTEX INC. - SIGNET — Levothyroxine Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Levothyroxine to APOTEX INC. - SIGNET?
Verified from 33 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MACLEODS PHARMACEUTICALS LIMITED | $785.2K | 33 | 100.0% |
APOTEX INC. - SIGNET sources Levothyroxine from 1 verified Indian supplier based on 33 customs records. The primary supplier is MACLEODS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does APOTEX INC. - SIGNET Compare to Nearest Levothyroxine Importers?
Buyers ranked immediately above and below #18 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 16 | CRESCENT PHARMA LIMITED | UNITED KINGDOM | $926.4K | 94 | $9.9K |
| 17 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $883.7K | 27 | $32.7K |
| 18 | APOTEX INC. - SIGNET ★ | CANADA | $804.1K | 33 | $24.4K |
| 1 | MACLEODS PHARMA USA,INC, | UNITED STATES | $800.0K | 16 | $50.0K |
APOTEX INC. - SIGNET ranks #18 among 235 Levothyroxine importers from India. Average shipment value of $24.4K compared to the market average of $144.6K. The closest competitors by value are CRESCENT PHARMA LIMITED and EVERSANA LIFE SCIENCE SERVICES.
Where Does APOTEX INC. - SIGNET Import Levothyroxine To?
Destination countries from 33 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $785.2K | 33 | 100.0% |
APOTEX INC. - SIGNET imports Levothyroxine to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $785.2K.
What Levothyroxine Formulations Does APOTEX INC. - SIGNET Import?
| Formulation | Value | Shipments |
|---|---|---|
| LEVOTHYROXINE TAB 100 MCG 1000S BTL-APOTEX, CANADA , (5652 QTY X PACK SIZE 1 X 1000 = 5652000 NOS) | $50.0K | 1 |
| LEVOTHYROXINE TAB 25 MCG 1000S BTL-APOTEX, CANADA , (7080 QTY X PACK SIZE 1 X 1000 = 7080000 NOS) | $50.0K | 1 |
| LEVOTHYROXINE TAB 88 MCG 1000S BTL-APOTEX, CANADA , (4788 QTY X PACK SIZE 1 X 1000 = 4788000 NOS) | $46.5K | 1 |
| LEVOTHYROXINE TAB 75 MCG 1000S BTL- APOTEX, CANADA , (QTY 4704 X PACK SIZE 1 X1000 = 4704000 NOS) | $43.6K | 1 |
| LEVOTHYROXINE TAB 112 MCG 1000S BTL-APOTEX, CANADA , (3948 QTY X PACK SIZE 1 X 1000 = 3948000 NOS) | $40.6K | 1 |
| LEVOTHYROXINE TAB 50 MCG 1000S BTL- APOTEX, CANADA , (4236 QTY X PACK SIZE 1 X 1000 = 4236000 NOS) | $38.0K | 1 |
| LEVOTHYROXINE TAB 150 MCG 1000S BTL-APOTEX, CANADA , (2952 QTY X PACK SIZE 1 X 1000 = 2952000 NOS) | $34.4K | 1 |
| LEVOTHYROXINE TAB 50 MCG 1000S BTL-APOTEX, CANADA , (3552 QTY X PACK SIZE 1 X 1000 = 3552000 NOS) | $32.0K | 1 |
| LEVOTHYROXINE TAB 25 MCG 1000S BTL-APOTEX, CANADA , (3504 QTY X PACK SIZE 1 X 1000 = 3504000 NOS) | $30.6K | 1 |
| LEVOTHYROXINE TAB 125 MCG 1000S BTL-APOTEX, CANADA , (2832 QTY X PACK SIZE 1 X 1000 = 2832000 NOS) | $30.3K | 1 |
APOTEX INC. - SIGNET imports 33 distinct Levothyroxine formulations from India. The top formulation is LEVOTHYROXINE TAB 100 MCG 1000S BTL-APOTEX, CANADA , (5652 Q with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Levothyroxine into Canada
What APOTEX INC. - SIGNET and other importers must comply with to import Levothyroxine from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Levothyroxine
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Levothyroxine from India and How Much Does APOTEX INC. - SIGNET Import?
India exported $34.0M worth of Levothyroxine through 2,385 shipments from 125 suppliers to 71 countries, serving 235 buyers globally. APOTEX INC. - SIGNET imports $785.2K of this total, accounting for 1.0% of India's Levothyroxine exports with 33 shipments from CANADA. This is verified from 33 customs shipment records covering 33 distinct formulations.
What Is the Average Order Value for APOTEX INC. - SIGNET's Levothyroxine Imports?
APOTEX INC. - SIGNET's average Levothyroxine order value is $23.8K per consignment, based on 33 shipments totaling $785.2K. APOTEX INC. - SIGNET is based in CANADA and ranks #18 among all Levothyroxine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Levothyroxine to APOTEX INC. - SIGNET?
APOTEX INC. - SIGNET sources Levothyroxine from 1 verified Indian supplier: MACLEODS PHARMACEUTICALS LIMITED ($785.2K, 100.0%). This is based on 33 customs records.
How Does APOTEX INC. - SIGNET Compare to Other Levothyroxine Importers?
APOTEX INC. - SIGNET ranks #18 among 235 Levothyroxine importers from India with a 1.0% market share. The top 3 importers are EVERSANA LIFE SCIENCES SERVICES,LLC ($8.9M), WOCKHARDT UK LIMITED ($5.2M), SUN PHARMA ANZ PTY LTD ($3.5M). APOTEX INC. - SIGNET processed 33 shipments from CANADA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Levothyroxine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Levothyroxine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX INC. - SIGNET matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX INC. - SIGNET's capped import value divided by total capped export value for Levothyroxine across all Indian exporters.
- 5.Verified Records: This page is backed by 33 individual customs records matching APOTEX INC. - SIGNET importing Levothyroxine, covering 33 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 71+ countries, 235+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Levothyroxine Import Data for APOTEX INC. - SIGNET
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX INC. - SIGNET's Levothyroxine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX INC. - SIGNET
Company Profile
Multiple products · $0 total trade · Multiple categories
APOTEX INC. - SIGNET × Levothyroxine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX INC. - SIGNET.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levothyroxine. For current order-level data, contact TransData Nexus.